NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹19 Cr | ₹4.69 Cr | ₹21 Cr | ₹15 Cr | ₹21 Cr |
What is the latest Short Term Loans and Advances ratio of NGL FINECHEM ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2026 | ₹19 Cr |
| Mar2025 | ₹4.69 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹21 Cr |
How is Short Term Loans and Advances of NGL FINECHEM Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2026 | ₹19 Cr | 301.77 | |
| Mar2025 | ₹4.69 Cr | -77.75 | |
| Mar2024 | ₹21 Cr | 40.13 | |
| Mar2023 | ₹15 Cr | -28.97 | |
| Mar2022 | ₹21 Cr | - | |
Compare Short Term Loans and Advances of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,742.0 Cr | -3.2% | 4.8% | 90% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -3.2% |
4.8% |
90% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses